The relevance of migraine in the clinical spectrum of mitochondrial disorders

被引:0
|
作者
Alberto Terrin
Luca Bello
Maria Lucia Valentino
Leonardo Caporali
Gianni Sorarù
Valerio Carelli
Ferdinando Maggioni
Massimo Zeviani
Elena Pegoraro
机构
[1] University of Padova,Department of Neuroscience, ERN Neuromuscular Center
[2] University of Padova,Department of Neurosciences
[3] IRCCS Istituto delle Scienze Neurologiche di Bologna,Programma di Neurogenetica
[4] University of Bologna,Department of Biomedical and Neuromotor Sciences (DIBINEM)
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Recent scientific evidence suggests a link between migraine and brain energy metabolism. In fact, migraine is frequently observed in mitochondrial disorders. We studied 46 patients affected by mitochondrial disorders, through a headache-focused semi-structured interview, to evaluate the prevalence of migraine among patients affected by mitochondrial disorders, the possible correlations between migraine and neuromuscular genotype or phenotype, comorbidities, lactate acid levels and brain magnetic resonance spectroscopy. We explored migraine-related disability, analgesic and prophylactic treatments. Diagnoses were achieved according to International Classification of Headache Disorders, 3rd edition. Lifetime prevalence of migraine was 61% (28/46), with high values in both sexes (68% in females, 52% in males) and higher than the values found in both the general population and previous literature. A maternal inheritance pattern was reported in 57% of cases. MIDAS and HIT6 scores revealed a mild migraine-related disability. The high prevalence of migraine across different neuromuscular phenotypes and genotypes suggests that migraine itself may be a common clinical manifestation of brain energy dysfunction. Our results provide new relevant indications in favour of migraine as the result of brain energy unbalance.
引用
收藏
相关论文
共 50 条
  • [41] Mitochondrial diseases in children: Clinical spectrum
    Erazo, R
    Shanske, S
    Di Mauro, S
    Vu, T
    Mabe, P
    Abdala, H
    Taratuto, AL
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 101 - 101
  • [42] THE EXPANDING CLINICAL SPECTRUM OF MITOCHONDRIAL DISEASES
    DEVIVO, DC
    BRAIN & DEVELOPMENT, 1993, 15 (01): : 1 - 22
  • [43] Clinical trials in mitochondrial disorders, an update
    Almannai, Mohammed
    El-Hattab, Ayman W.
    Ali, May
    Soler-Alfonso, Claudia
    Scaglia, Fernando
    MOLECULAR GENETICS AND METABOLISM, 2020, 131 (1-2) : 1 - 13
  • [44] Clinical presentation of mitochondrial disorders in childhood
    Munnich, A
    Rotig, A
    Chretien, D
    Cormier, V
    Bourgeron, T
    Bonnefont, JP
    Saudubray, JM
    Rustin, P
    JOURNAL OF INHERITED METABOLIC DISEASE, 1996, 19 (04) : 521 - 527
  • [45] Mitochondrial disorders: Clinical and genetic features
    Simon, DK
    Johns, DR
    ANNUAL REVIEW OF MEDICINE, 1999, 50 : 111 - 127
  • [47] ENDORPHINS, CLINICAL RELEVANCE IN PAIN AND NEUROLOGICAL DISORDERS
    TERENIUS, L
    WAHLSTROM, A
    ACTA NEUROCHIRURGICA, 1981, 59 (3-4) : 277 - 278
  • [49] Quantifying Clinical Relevance in Treatments for Psychiatric Disorders
    Citrome, Leslie
    CLINICAL THERAPEUTICS, 2011, 33 (12) : B1 - B2
  • [50] Animal models for mucopolysaccharidosis disorders and their clinical relevance
    Haskins, Mark E.
    ACTA PAEDIATRICA, 2007, 96 : 56 - 62